PIK3R1 and myeloid sarcoma: Through a profiling of the miRNAs differentially expressed in serum and plasma of patients with MS and a subsequent computational analysis, it was found that miR-155 has as targets PIK3R1 and PIK3CA, which are considered to be MS risk genes.